Mr Christopher Ogden, Urologist

Mr Christopher Ogden MB BS MS FRCSEd FRCSEng FRCSUrol FEBU

Urologist

MB BS MS FRCSEd FRCSEng FRCSUrol FEBU

Areas of expertise

  • Prostate cancer screening
  • Da Vinci nerve sparing robotic prostate surgery
  • High intensity focused ultrasound treatment for prostate cancer (HiFU)
  • Urological oncology
  • Kidney disorders

Recommendations for Mr Ogden

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byMr Paul Cathcart, Urological Surgeon

    Mr Christopher Ogden is a top prostate cancer specialist with extensive operative experience.

  • byProf. Mark Emberton, Professor of Urology

    Mr Christopher Ogden is probably the best prostate cancer specialist in the UK.

  • byMr Dan Wood, Urological Surgeon

    Recommended Urologist

  • by Mr Hashim Uddin Ahmed, Urologist

    Recommended Urologist

  • byMr Paul Cathcart, Urological Surgeon

    Mr Christopher Ogden is a top prostate cancer specialist with extensive operative experience.

  • byProf. Mark Emberton, Professor of Urology

    Mr Christopher Ogden is probably the best prostate cancer specialist in the UK.

  • byMr Dan Wood, Urological Surgeon

    Recommended Urologist

  • by Mr Hashim Uddin Ahmed, Urologist

    Recommended Urologist

  • Address

    • The Princess Grace Hospital

      42–52 Nottingham Place, London, W1U 5NY

    • Chelsea Outpatient Centre

      280 King's Road, London, SW3 5AW

    • The Prostate Centre

      18 Devonshire Street, London, W1G 7AQ

    • Telephone or video consultation

      Virtual

  • Royal Marsden Hospital

    Fulham Road, London, SW3 6JJ

  • About Mr Christopher Ogden

    GMC number: 2957661

    Year qualified: 1984

    Place of primary qualification: University of London

    Areas of expertise

    • Cancer of the bladder
    • Da vinci nerve sparing robotic prostate surgery
    • Focal therapy (prostate cancer)
    • Haematuria (blood in urine)
    • High intensity focused ultrasound treatment for prostate cancer (HiFU)
    • Holmium laser enucleation of the prostate (HoLEP)
    • Kidney and prostate
    • Kidney disorders
    • Kidney stone prevention
    • Laparoscopic surgery for kidney disorders
    • Major pelvic surgery including neo-bladder construction
    • Nephrectomy
    • Prostate cancer screening
    • Prostatectomy
    • Pyeloplasty
    • Radical robotic prostatectomy
    • Raised PSA
    • Renal colic
    • Rigid & flexible ureterorenoscopy and laser fragmentation of stones
    • Testicular pain
    • Urinary incontinence
    • Urological malignancy
    • Urological oncology

    Professional memberships

    Royal College of Surgeons of England
    British Medical Association (BMA)
    General Medical Council

    Articles by Mr Christopher Ogden

    Focal therapies in prostate cancer

    Robotic assisted perineal prostatectomy

    Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer

    Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer

    An exploratory study of dose escalation versus standard focal high intensity focused ultrasound for treating non-metastatic prostate cancer

    Evaluation of functional outcomes following a second focal-HIFU in men with primary localised, non-metastatic prostate cancer; results from the high intensity focused ultrasound evaluation and assessment of treatment (heat) registry

    Supplementary material

    A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer

    Mp30-11 predictors of poor functional outcomes after focal high intensity focussed ultrasound (HIFU)

    MP30-10 HIFU dose escalation leads to fewer recurrences in following focal HIFU in prostate cancer

    Medium-term outcomes after whole-gland high-intensity focused ultrasound for the treatment of nonmetastatic prostate cancer from a multicentre registry cohort